Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay

Journal of Infectious Diseases

Volumn 182, Issue 1, 2000, Pages 306-310

  Olsen, Sonja J ^a,b   Sarid, Ronit ^a,c   Chang, Yuan ^a   Moore, Patrick S ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; ITALY; KAPOSI SARCOMA; OPEN READING FRAME; PEPTIDE MAPPING; PRIORITY JOURNAL; SERODIAGNOSIS;

ANTIGENS, VIRAL; BLOTTING, WESTERN; EPITOPE MAPPING; EVALUATION STUDIES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; PEPTIDE MAPPING; RECOMBINANT PROTEINS; SARCOMA, KAPOSI;

EID: 0033943983     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315689     Document Type: Article

References (14)

1. 1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266: 1865-69.
2. 2. Olsen SJ, Moore PS. Kaposi's sarcoma-associated herpesvirus (KSHV/ HHV8) and the etiology of KS. In: Freidman H, Medveczky P, Bendinelli M, eds. Herpesviruses and immunity. New York: Plenum, 1999:115-47.
3. 3. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
4. 4. Moore PS, Gao SJ, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996;70:549-58.
5. 5. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348: 1133-8.
6. 6. Chandran B, Bloomer C, Chan SR, Zhu L, Goldstein E, Horvat R. Human herpesvinis-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 1998;249:140-9.
7. 7. Raab MS, Albrecht JC, Birkmann A, et al. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 1998;72:6725-31.
8. 8. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies to Kaposi's sarcoma associated herpesvirus-related latent nuclear antigens prior to onset of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
9. 9 Rainbow L, Platt GM, Simpson GR, et al. The 226-to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) is encoded by ORF73 and is a component of the latency-associated nuclear antigen. J Virol 1997;71:5915-21.
10. 10. Kedes D, Lagunoff M, Renne R, Ganem D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 1997;100:2606-10.
11. 11. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi sarcoma associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996;93:14862-7.
12. 12. Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8 infected BCBL-1 cells. Virology 1999;256: 381-92.
13. 13. Gnann JJ, Schwimmbeck PL, Nelson JA, Truax AB, Oldstone MB. Diagnosis of AIDS by using a 12 -amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis 1987; 156:261-7.
14. 14. Zong JC, Ciufo DM, Alcendor DJ, et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999;73: 4156-70.